Hepatology • Portal Hypertension

Variceal Bleeding Explained: Pathophysiology, Clinical Features and Management Principles

Variceal bleeding is a life-threatening complication of portal hypertension. It occurs when dilated portosystemic collateral veins — most commonly in the distal esophagus — rupture and cause upper gastrointestinal bleeding.

Dr. Seneth Gajasinghe, MBBS, MD Published: 8 June 2026 Updated: 8 June 2026 16 min read Reviewed Content

Portal hypertension has two major clinical branches.

One branch produces ascites, SBP and hepatorenal syndrome.

The other branch produces portosystemic collaterals, varices and variceal bleeding.

Variceal bleeding is therefore not a separate disease. It is the bleeding complication of portal hypertension — and understanding it requires understanding why portal pressure rises in cirrhosis, which was covered in Portal Hypertension Explained.

Key Concept

Varices form because the portal venous system is trying to bypass the high-resistance cirrhotic liver. This bypass is useful for decompressing portal pressure but dangerous because the collateral veins are thin-walled and carry high-pressure blood.

Portal Hypertension: Two Major Clinical Branches

Branch 1: Portal hypertension → ascites → SBP → hepatorenal syndrome
Branch 2: Portal hypertension → portosystemic collaterals → varices → variceal bleeding

Learning Objectives

  • Define variceal bleeding
  • Explain why varices form in portal hypertension
  • Identify common sites of portosystemic collaterals
  • Explain why varices rupture
  • Recognise clinical features of acute variceal bleeding
  • Understand the role of endoscopy in diagnosis and treatment
  • Explain band ligation in simple terms
  • Distinguish primary from secondary prophylaxis

What Is Variceal Bleeding?

Variceal bleeding is bleeding from dilated portosystemic collateral veins that develop because of portal hypertension.

The most common clinically important site is the distal esophagus, where portal venous blood from the left gastric vein communicates with the azygos system (systemic venous drainage). When these collateral veins enlarge under sustained high pressure, they become esophageal varices.

Variceal bleeding is usually severe because portal venous pressure is high and variceal walls are thin. A single variceal rupture can cause massive haemorrhage with rapid haemodynamic compromise.

Side-by-side diagram comparing a normal esophagus with a normal mucosal appearance against an esophagus with dilated submucosal varices visible as prominent blue-purple vessels
Figure 1. Normal esophagus versus variceal esophagus. Dilated submucosal varices are visible as prominent vessels in the distal esophagus, carrying portal blood at high pressure.

Why Do Varices Form?

In cirrhosis, scarring and architectural distortion increase resistance to portal blood flow. Portal pressure rises. The body responds by opening alternative venous channels to bypass the high-resistance liver and return blood to the systemic circulation.

These alternative channels are called portosystemic collaterals. When collaterals form and enlarge at the esophagus or stomach, they are termed varices.

Cirrhosis ↑ Intrahepatic resistance Portal hypertension Portosystemic collateral formation Esophageal / gastric varices

When Does Portal Hypertension Become Dangerous?

Portal hypertension becomes clinically important when the pressure gradient is high enough to produce complications such as varices, ascites and bleeding.

The hepatic venous pressure gradient (HVPG) is used to estimate portal pressure in specialist settings. Two thresholds are especially important:

HVPG Level Clinical Meaning
>10 mmHg Clinically significant portal hypertension. Varices and decompensation become more likely.
>12 mmHg Bleeding from varices becomes possible. Reducing portal pressure below this level reduces bleeding risk.
Pressure Threshold Pearl

Varices usually form when portal pressure becomes clinically significant. Bleeding risk rises when portal pressure is high enough to overcome the strength of the variceal wall. This is why non-selective beta-blockers, vasoactive drugs and TIPS all work by reducing portal pressure.

Key Teaching Point

Varices are bypass channels. They are physiologically useful — they decompress the portal system — but clinically dangerous because they carry high-pressure portal blood through thin-walled vessels that can rupture. The body's attempt to compensate creates the risk.

Flow diagram showing cirrhosis increasing intrahepatic resistance causing portal hypertension which opens portosystemic collaterals forming esophageal and gastric varices
Figure 2. From portal hypertension to varices. Rising portal pressure forces the venous system to open collateral channels — which become varices when they enlarge.

Common Sites of Portosystemic Collaterals

Portal hypertension opens collateral pathways wherever portal and systemic venous systems naturally communicate. Four clinically important sites exist:

SitePortal TributarySystemic DrainageClinical Result
Distal esophagusLeft gastric veinAzygos systemEsophageal varices
StomachShort gastric veinsSystemic gastric veinsGastric varices
RectumSuperior rectal veinMiddle and inferior rectal veinsRectal varices
UmbilicusParaumbilical veinsSuperficial abdominal veinsCaput medusae
Exam Pearl

Most important bleeding site = distal esophagus. The left gastric–azygos connection is where clinically significant bleeding most commonly occurs. All four collateral sites are testable, but esophageal varices carry the greatest clinical significance.

Anatomical diagram showing the four main portosystemic collateral sites: distal esophagus gastric fundus rectum and umbilicus with portal and systemic vein connections
Figure 3. Sites of portosystemic collaterals. The distal esophagus is the most clinically important site, but all four locations can develop varices under sustained portal hypertension.

Esophageal vs Gastric Varices

Both esophageal and gastric varices are important, but they differ in frequency, bleeding pattern and management.

FeatureEsophageal VaricesGastric Varices
FrequencyMore commonLess common
Common locationDistal esophagusFundus or cardia of stomach
Endoscopic treatmentBand ligationOften glue injection or specialist therapy
Bleeding patternCommon, can be massiveLess frequent but often severe
Exam focusVery high priorityModerate — know the difference
Comparison diagram showing esophageal varices at the distal esophagus and gastric varices at the fundus and cardia with different endoscopic appearances and treatment approaches
Figure 4. Esophageal versus gastric varices. Esophageal varices at the gastroesophageal junction are more common and treated with band ligation. Gastric varices require specialist endoscopic or radiological management.

Why Do Varices Rupture?

Varices rupture when wall tension exceeds the structural strength of the variceal wall. Several factors combine to increase rupture risk:

  • High portal pressure — the driving force transmitting pressure into varices
  • Large variceal size — wall tension increases as vessel radius increases (Laplace's law)
  • Thin variceal wall — varices have a thinner wall than normal blood vessels
  • Red wale marks — longitudinal red streaks visible on endoscopy indicating high rupture risk
  • Severe liver disease — advanced liver failure worsens portal haemodynamics and reduces the ability to withstand haemorrhage
Rupture Rule

Large varix + high pressure + thin wall = rupture risk. The Laplace relationship means that as a varix enlarges, its wall tension rises disproportionately — small increases in size significantly increase rupture probability.

Red Wale Marks

Red wale marks are longitudinal red streaks on the surface of varices seen on endoscopy. They represent areas of thin epithelium over distended vessels and are an independent predictor of imminent variceal rupture. Their presence escalates the urgency of prophylactic treatment.

Diagram illustrating why varices rupture showing high portal pressure large variceal size thin wall and red wale marks as combined risk factors leading to rupture
Figure 5. Why varices rupture. Wall tension rises with vessel size (Laplace). Combined with high portal pressure, thin walls and red wale marks, the risk of rupture becomes critical.

Risk Factors for First Variceal Bleed

Not all varices bleed. The risk of a first variceal bleed depends on variceal size, endoscopic appearance, portal pressure and severity of liver disease.

Risk Factor Why It Matters
Large varices Larger radius increases wall tension, making rupture more likely.
Red wale marks Endoscopic signs of thin, high-risk areas on the variceal wall.
Severe portal hypertension Higher pressure increases variceal wall tension and rupture risk.
Advanced cirrhosis Poor liver reserve increases bleeding risk and worsens outcome after bleeding.
Active alcohol use May worsen portal pressure, liver inflammation and adherence to prophylaxis.
Exam Tip

The three highest-yield predictors of first variceal bleed are large varices, red wale marks, and advanced liver disease.

Infographic showing small varices large varices and large varices with red wale marks to explain increasing risk of first variceal bleeding
Figure 6. Red wale marks and first bleed risk. Large varices with red wale marks have the highest risk of rupture.

Clinical Presentation

Variceal bleeding is an upper gastrointestinal bleeding emergency. The presentation reflects both the site of bleeding and the underlying severity of liver disease.

  • Haematemesis — vomiting of fresh red blood or altered blood (coffee grounds)
  • Melaena — black tarry stools from digested upper GI blood
  • Postural dizziness — reflects significant blood loss and hypovolaemia
  • Syncope — in acute major haemorrhage
  • Haemodynamic shock — hypotension, tachycardia, pallor, cold peripheries
  • Features of chronic liver disease — jaundice, spider naevi, leukonychia, ascites, splenomegaly
Critical Clinical Rule

In a patient with cirrhosis presenting with haematemesis, variceal bleeding must be assumed until proven otherwise by endoscopy. Resuscitation and urgent endoscopic assessment should not be delayed while waiting for other investigations.

Diagnosis

Upper gastrointestinal endoscopy (OGD) is the key diagnostic and therapeutic investigation. It should be performed urgently — usually within 12 hours of presentation, or immediately if there is haemodynamic instability.

Endoscopy identifies:

  • Source of bleeding — confirms varices are responsible (versus peptic ulcer, Mallory-Weiss tear, etc.)
  • Size of varices — small, medium or large
  • Red wale marks — high rupture-risk stigmata
  • Active bleeding or recent stigmata — confirms active haemorrhage
  • Need for endoscopic therapy — allows immediate band ligation
Key Principle

Endoscopy is both diagnostic and therapeutic. In the same procedure, the diagnosis is confirmed and band ligation can be performed. This dual role makes urgent endoscopy essential in any suspected variceal bleed.

Acute Management Principles

Acute variceal bleeding management has three parallel goals: stabilise the patient, reduce portal pressure, and control the bleeding source.

  • 1ABC resuscitation — airway protection (especially in encephalopathic patients), IV access, fluid resuscitation.
  • 2Restrictive transfusion strategy — transfuse to haemoglobin of 70–80 g/L. Over-transfusion raises portal pressure and increases rebleeding risk.
  • 3Vasoactive drug — terlipressin or somatostatin analogues (e.g. octreotide) reduce portal pressure, constrict splanchnic vasculature, and reduce variceal blood flow. Start before endoscopy.
  • 4Antibiotic prophylaxis — given to all cirrhotic patients with GI bleeding. Reduces bacterial infection, SBP risk, and rebleeding. Quinolones or cephalosporins are typically used.
  • 5Urgent endoscopy — confirms diagnosis and allows direct haemostatic therapy. Target within 12 hours of presentation.
  • 6Band ligation — first-line endoscopic therapy for active esophageal variceal bleeding. Immediate haemostasis in most cases.
Exam Tip

Three key concepts always tested: (1) vasoactive drugs reduce portal pressure before endoscopy, (2) antibiotics are mandatory in all GI bleeding in cirrhosis, (3) restrictive transfusion strategy — not liberal transfusion — is the evidence-based approach.

Management flowchart for acute variceal bleeding showing ABC resuscitation restrictive transfusion vasoactive drugs antibiotics urgent endoscopy and band ligation
Figure 7. Acute variceal bleeding management overview. Resuscitation, pharmacological portal pressure reduction, antibiotic prophylaxis, and urgent endoscopic band ligation form the integrated treatment strategy.

Band Ligation Explained

Endoscopic variceal band ligation (EVL) places small rubber bands around varices through the endoscope. It is the first-line endoscopic therapy for bleeding esophageal varices.

How band ligation works — step by step
Endoscope advances to varix
↓ Varix suctioned into a cap attached to the scope tip
↓ Rubber band deployed around the base of the varix
↓ Varix strangulated — blood flow cut off
↓ Varix thromboses over the following days
↓ Varix sloughs off, leaving a superficial ulcer that heals
↓ Bleeding controlled

Multiple bands may be placed in a single session. Sessions are typically repeated every 2–4 weeks until varices are eradicated. Band ligation is both a haemostatic and prophylactic procedure — it is used acutely to control bleeding and electively to eradicate varices and prevent future bleeds.

Band Ligation vs Sclerotherapy

Endoscopic variceal ligation (EVL) has largely replaced injection sclerotherapy as the preferred endoscopic technique. EVL has fewer complications, lower rebleeding rates and better variceal eradication. Know that sclerotherapy exists as an alternative but EVL is now standard.

What If Bleeding Cannot Be Controlled?

Most esophageal variceal bleeds can be controlled with vasoactive drugs and endoscopic band ligation. However, some patients continue to bleed or rebleed early despite standard therapy.

In that situation, rescue therapy is needed. The goal is to temporarily control haemorrhage and reduce portal pressure more definitively.

Persistent bleeding Repeat endoscopic therapy Balloon tamponade / covered stent as bridge TIPS Portal decompression
What Is TIPS?

TIPS stands for Transjugular Intrahepatic Portosystemic Shunt. It creates an artificial channel between the portal vein and hepatic vein inside the liver. This diverts blood away from the high-pressure portal system, lowers portal pressure and reduces variceal bleeding risk. TIPS is used for uncontrolled or recurrent variceal bleeding when standard therapy is insufficient.

Flowchart showing rescue therapy for uncontrolled variceal bleeding including repeat endoscopy balloon tamponade covered stent and TIPS for portal decompression
Figure 8. Rescue therapy for uncontrolled variceal bleeding. Balloon tamponade or covered stent may act as a bridge, while TIPS provides portal decompression.

Primary vs Secondary Prophylaxis

TypeWhen GivenAim
Primary prophylaxisVarices present but no previous variceal bleedPrevent the first bleed
Secondary prophylaxisAfter a variceal bleed has occurredPrevent recurrent bleeding

Primary Prophylaxis

Patients with medium or large varices on endoscopy, or varices with red wale marks, are at significant risk of a first bleed. Non-selective beta-blockers (e.g. propranolol, carvedilol) reduce portal pressure by reducing cardiac output and splanchnic blood flow. Band ligation is an alternative for patients who cannot tolerate beta-blockers.

Secondary Prophylaxis

After a variceal bleed, rebleeding risk is high — historically up to 60–70% without prophylaxis. Secondary prophylaxis combines non-selective beta-blockers with repeated band ligation sessions until varices are eradicated. This combination is more effective than either alone.

Exam Tip

Secondary prophylaxis is the highest-yield prophylaxis concept. After a first variceal bleed, always start non-selective beta-blocker + band ligation. Remember: non-selective (not cardioselective) beta-blockers are needed because splanchnic vasoconstriction requires beta-2 blockade.

Diagram contrasting primary prophylaxis for patients with varices but no previous bleed against secondary prophylaxis after a variceal bleed has occurred showing goals and treatment approaches
Figure 9. Primary versus secondary prophylaxis. Primary prevents the first bleed; secondary prevents recurrence after a bleed has occurred. Both are important but secondary prophylaxis carries the highest urgency.

Prognosis

Variceal bleeding indicates clinically significant portal hypertension and advanced liver disease. Mortality depends on several factors:

  • Severity of underlying liver disease (Child-Pugh class, MELD score)
  • Haemodynamic status at presentation — shock worsens outcomes
  • Early rebleeding within the first five days
  • Bacterial infection — including SBP precipitated by the bleed
  • Renal dysfunction — including hepatorenal syndrome
Interaction with Other Complications

Variceal bleeding, SBP and HRS often interact. GI bleeding precipitates bacterial infection — which is why antibiotic prophylaxis is mandatory. Infection and haemorrhage together worsen circulatory dysfunction and increase the risk of hepatorenal syndrome. This interconnection explains why managing cirrhosis requires attention to all complications simultaneously.

Infographic showing outcomes of variceal bleeding including shock infection hepatorenal syndrome death and improved outcomes with early treatment and secondary prophylaxis
Figure 10. Outcomes of variceal bleeding. Early treatment controls bleeding and prevents complications, while delayed or failed control may lead to shock, infection, hepatorenal syndrome and death.

One-Minute Variceal Bleeding Revision

Portal hypertension Portosystemic collaterals Esophageal varices Rupture → haematemesis Resuscitation + vasoactive drug + antibiotics Urgent endoscopy + band ligation Secondary prophylaxis
One-minute revision summary of variceal bleeding showing portal hypertension collateral formation variceal rupture emergency management and prophylaxis
Figure 11. One-minute variceal bleeding revision: from portal hypertension to collateral formation, rupture, emergency management, and prophylaxis.

High-Yield Exam Pearls

Quick Memory Pattern

Varices = portosystemic collaterals
Most common site = distal esophagus (left gastric → azygos)
Varices form because portal blood bypasses the cirrhotic liver
Large varices bleed more — wall tension increases with radius
Red wale marks = high rupture risk
OGD = diagnostic AND therapeutic
Band ligation = first-line for esophageal varices
Antibiotics mandatory in all GI bleeding in cirrhosis
Restrictive transfusion — not liberal
Secondary prophylaxis = beta-blocker + band ligation

Exam Tips — Variceal Bleeding
  • Varices are bypass channels — not pathological growths. They form because portal blood is trying to return to the systemic circulation.
  • Red wale marks — know what they are, what they predict, and that they are seen on endoscopy.
  • Vasoactive drugs before endoscopy — terlipressin or octreotide should be started as soon as variceal bleeding is suspected, before endoscopy.
  • Antibiotics are mandatory — all cirrhotic patients with GI bleeding, regardless of clinical signs of infection.
  • Restrictive transfusion — target Hb 70–80 g/L. Over-transfusion raises portal pressure and worsens bleeding risk.
  • Non-selective beta-blockers — must be non-selective (not cardioselective) to achieve both beta-1 and beta-2 blockade for portal pressure reduction.
  • Secondary prophylaxis combines beta-blocker AND band ligation — combination is more effective than either alone.
  • Caput medusae — dilated superficial abdominal veins radiating from umbilicus due to paraumbilical vein collaterals.
  • HVPG thresholds — >10 mmHg = clinically significant portal hypertension; >12 mmHg = variceal bleeding risk rises.
  • TIPS treats portal pressure — it is used when bleeding is uncontrolled or recurrent despite standard therapy.
  • Risk of first bleed is highest with large varices, red wale marks and advanced liver disease.

Key Takeaways

  • Variceal bleeding is the bleeding complication of portal hypertension, not a separate disease
  • Varices are portosystemic collaterals — bypass channels that form when the cirrhotic liver obstructs portal flow
  • Most important site is the distal esophagus via the left gastric–azygos connection
  • Varices rupture when wall tension exceeds wall strength — large varices at highest risk (Laplace's law)
  • Red wale marks on endoscopy predict high imminent rupture risk
  • Clinically significant portal hypertension begins around HVPG >10 mmHg; bleeding risk rises especially above HVPG >12 mmHg
  • Risk factors for first bleed include large varices, red wale marks, high portal pressure and advanced cirrhosis
  • If bleeding cannot be controlled with standard therapy, rescue options include repeat endoscopy, temporary tamponade/stent and TIPS
  • TIPS reduces variceal bleeding by treating the pressure problem — portal hypertension
  • Acute management: resuscitate, give vasoactive drug, give antibiotics, perform urgent endoscopy with band ligation
  • Restrictive transfusion strategy — target Hb 70–80 g/L to avoid raising portal pressure
  • Band ligation strangulates varices, stops blood flow, and causes thrombosis and fibrosis
  • Primary prophylaxis prevents the first bleed; secondary prophylaxis prevents rebleeding
  • Secondary prophylaxis = non-selective beta-blocker combined with band ligation sessions
  • Variceal bleeding precipitates infection and can trigger hepatorenal syndrome
  • Prognosis depends on severity of liver disease, haemodynamic status, and early rebleeding

Frequently Asked Questions

What causes variceal bleeding?+
Variceal bleeding is caused by rupture of dilated portosystemic collateral veins — varices — that develop because of portal hypertension. In cirrhosis, scarring increases resistance to portal blood flow, raising portal pressure. The body opens collateral channels to bypass the liver. When these channels enlarge at the esophagus or stomach, they become varices carrying high-pressure blood through thin walls — a combination that can cause massive haemorrhage when they rupture.
Why do varices form in portal hypertension?+
Varices form because portal hypertension raises the pressure in the portal venous system. The body responds by opening collateral venous channels at sites where portal and systemic veins naturally communicate — particularly the distal esophagus, stomach, rectum and umbilicus. These collaterals enlarge progressively under sustained high pressure, becoming varices. They are essentially the venous system's attempt to decompress the portal circulation by bypassing the high-resistance cirrhotic liver.
What is clinically significant portal hypertension?+
Clinically significant portal hypertension means portal pressure is high enough to cause complications such as varices, ascites or decompensation. In specialist practice, it is often defined by a hepatic venous pressure gradient (HVPG) above 10 mmHg. Variceal bleeding becomes more likely when HVPG exceeds about 12 mmHg. This is why treatments that reduce portal pressure — such as non-selective beta-blockers, vasoactive drugs and TIPS — reduce bleeding risk.
Why do varices rupture?+
Varices rupture when wall tension exceeds the structural strength of the variceal wall. According to Laplace's law, wall tension increases as vessel radius increases — so larger varices are under greater mechanical stress. Combined with high intraluminal portal pressure and a thin variceal wall, rupture risk becomes significant. Red wale marks on endoscopy are superficial mucosal changes indicating areas of particularly thin and vulnerable wall, representing the highest-risk lesions.
What are red wale marks?+
Red wale marks are longitudinal red streaks on the surface of varices seen on upper GI endoscopy. They represent areas of particularly thin epithelium overlying distended, high-pressure variceal vessels. Red wale marks are an important endoscopic predictor of imminent variceal rupture and significantly increase the urgency of prophylactic treatment. Their presence on medium or large varices is an indication for primary prophylaxis even before a bleed has occurred.
Why is variceal bleeding dangerous?+
Variceal bleeding is dangerous for several reasons: portal venous pressure is high, so bleeding is often rapid and massive; patients with cirrhosis already have impaired coagulation from reduced hepatic synthesis of clotting factors; haemorrhage precipitates bacterial infection, worsening circulatory dysfunction; bleeding can trigger hepatic encephalopathy; and the stress of haemorrhage can precipitate hepatorenal syndrome. Mortality from acute variceal bleeding remains significant, particularly in patients with advanced liver disease.
What is band ligation?+
Endoscopic variceal band ligation (EVL) is the first-line endoscopic therapy for esophageal varices. The procedure uses an endoscope fitted with a cap containing pre-loaded rubber bands. Each varix is suctioned into the cap and a rubber band is deployed around its base, strangulating it. The varix thromboses and scleroses over several days, then sloughs off, leaving a superficial ulcer that heals. Sessions are repeated every 2–4 weeks until all varices are eradicated. EVL is used both to treat active bleeding and to prevent future bleeds.
What is the difference between esophageal and gastric varices?+
Esophageal varices form at the distal esophagus via the left gastric–azygos venous connection. They are more common and are the primary target of endoscopic band ligation. Gastric varices form at the gastric fundus or cardia via the short gastric veins and are less common but tend to bleed more severely when they do rupture. Gastric varices are harder to treat endoscopically — they often require tissue adhesive injection (glue), balloon-occluded retrograde transvenous obliteration (BRTO) or TIPS rather than standard band ligation.
Can varices occur without cirrhosis?+
Yes. Varices can occur in any condition causing portal hypertension, not only cirrhosis. Non-cirrhotic causes include portal vein thrombosis, Budd-Chiari syndrome (hepatic vein outflow obstruction), schistosomiasis (a major cause globally), congenital hepatic fibrosis, and myeloproliferative disorders causing portal vein thrombosis. In these patients, liver function may be relatively preserved, so prognosis after variceal bleeding is often better than in cirrhotic patients.
Can variceal bleeding recur?+
Yes — rebleeding risk is very high after a first variceal bleed, historically reported at 60–70% within one year without prophylaxis. Early rebleeding (within five days of the initial bleed) is particularly dangerous and is associated with high short-term mortality. This is why secondary prophylaxis — combining non-selective beta-blockers with repeated band ligation sessions until variceal eradication — is mandatory after any variceal bleed.
What is TIPS in variceal bleeding?+
TIPS stands for Transjugular Intrahepatic Portosystemic Shunt. It is a radiological procedure that creates a channel between the portal vein and hepatic vein inside the liver. This allows portal blood to bypass the high-resistance cirrhotic liver and drain into the systemic circulation, reducing portal pressure. In variceal bleeding, TIPS is used when bleeding cannot be controlled with standard therapy or when there is high risk of early rebleeding.
What is the difference between primary and secondary prophylaxis?+
Primary prophylaxis is given to patients who have varices but have never had a variceal bleed — the aim is to prevent the first bleed. It typically involves non-selective beta-blockers (propranolol or carvedilol) for medium or large varices, with band ligation as an alternative. Secondary prophylaxis is given after a variceal bleed has already occurred — the aim is to prevent recurrence. It combines non-selective beta-blockers with repeated band ligation sessions until variceal eradication. The combination is more effective than either therapy alone.

References

  1. de Franchis R; Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop. J Hepatol. 2015;63(3):743–752.
  2. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–938.
  3. European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
  4. Bosch J, Abraldes JG, Berzigotti A, Garcia-Tsao G. The clinical use of HVPG measurements in chronic liver disease. Nat Rev Gastroenterol Hepatol. 2009;6(10):573–582.
  5. Tripathi D, Stanley AJ, Hayes PC, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–1704.
  6. Lo GH, Lai KH, Cheng JS, et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology. 2001;33(5):1060–1064.
  7. Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368(1):11–21.
Medical Education Disclaimer

This article is intended for medical education only. It is designed for medical students, intern doctors, and junior doctors and does not constitute clinical advice. Always refer to current local guidelines and specialist hepatological input when managing patients with variceal bleeding.